Skip to main content
. 2019 Dec 17;9(12):e031674. doi: 10.1136/bmjopen-2019-031674

Figure 1.

Figure 1

Participant flow through the study. NAI, neuraminidase inhibitor; NIHR WTCRF, National Institute for Health Research Wellcome Trust Clinical Research Facility; POCT, point-of-care test.